Why not work on T and NK cells in the Kunkel laboratory?

Related Experiment Video

Updated: Aug 4, 2026

Interview: Glycolipid Antigen Presentation by CD1d and the Therapeutic Potential of NKT cell Activation
18:08

Interview: Glycolipid Antigen Presentation by CD1d and the Therapeutic Potential of NKT cell Activation

Published on: January 1, 2008

D Kabelitz1

  • 1Institute of Immunology, University of Kiel, Kiel, Germany. kabelitz@immunologie.uni-kiel.de

Lupus
|April 24, 2003
PubMed

Coming from Hans Wigzell's laboratory in Uppsala, Sweden, I joined the Kunkel laboratory in 1981 to spend a post-doctoral fellowship period financed by the German Research Organization. While I initially worked with Nick Chiorazzi in an attempt to generate monoclonal antibody-secreting human B-cell hybridomas, I later studied the in vitro effects of tumor promoters on human natural killer cells and collaborated with Mary Crow on some aspects of the so-called autologous mixed lymphocyte reaction. Working in the stimulating atmosphere of the Kunkel laboratory was an exceptional experience. I was particularly impressed by the efficient organization of clinical research at Rockefeller University. The following is a very personal resumee of my stay in the Kunkel laboratory.

More Related Videos

An Efficient and Simple Method to Establish NK and T Cell Lines from Patients with Chronic Active Epstein-Barr Virus Infection09:43

An Efficient and Simple Method to Establish NK and T Cell Lines from Patients with Chronic Active Epstein-Barr Virus Infection

Published on: March 30, 2018

Purification and Expansion of Mouse Invariant Natural Killer T Cells for in vitro and in vivo Studies08:37

Purification and Expansion of Mouse Invariant Natural Killer T Cells for in vitro and in vivo Studies

Published on: February 15, 2021

Related Concept Videos

Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...